CardioKinetix raises $50m, inks buyout deal with Edwards Lifesciences

CardioKinetix signs an exclusive option-to-buy agreement with Edwards Lifesciences in connection with a $50 million financing round.

CardioKinetix Inc., Edwards Lifesciences

News Well, Funding Roundup, Mergers & Acquisitions, Venture Capital/Private Equity

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1zGsLSL